Navigation Links
Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results

BALTIMORE, March 18 /PRNewswire-FirstCall/ -- Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, reports its financial results for the third fiscal quarter ended January 31, 2009. Full details of the Company's financial results are available in the Company's Form 10-Q at

Total revenues for the third quarter of fiscal 2009 increased to $1,052,175, compared to $624,940 for the same period in 2008. The Company derived its revenues from its Personalized Oncology and its Preclinical eValuation businesses.

Total operating expenses for the third fiscal quarter of 2009 were $1,696,457 compared to $319,998 for the same period of last year. Third quarter 2009 operating expenses included the following:

Research and development expenses were $435,274, compared to $0.00 for the comparable prior period in fiscal 2008. The increase of $435,274 was primarily related to the Company's effort to build its preclinical platform and drug pipeline and develop its drug, SG410. In addition, the Company incurred expenses related to its business development activities and personnel.

The costs of personalized oncology and preclinical eValuation services were $898,777 for the quarter ended January 31, 2009, as compared to $201,222 in the quarter ended January 31, 2008. The increase in personalized oncology costs relates mainly to the overall growth in the business and a $250,000 payment to fund the cost of a Personalized Vaccine(TM) program the Company entered into during the current quarter. The Personalized Vaccine program is structured such that the cost to establish the program is incurred primarily in the third and fourth quarter; if the program successfully continues i

SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
2. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
3. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
4. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
5. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
6. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
7. Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value
8. Canadian Government Announces Funding for Leading Biotechnology Firms Project
9. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
10. FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product
11. PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprovas Enantiomers of DOTAP Chloride in Immunotherapies
Post Your Comments:
(Date:10/9/2015)... and ROCKVILLE, Md. , ... a privately-held biotechnology company developing next generation vaccines ... it has entered into an exclusive worldwide licensing ... for the treatment or prevention of any and ... the agreement, Immunomic Therapeutics will receive an upfront ...
(Date:10/9/2015)... ... October 09, 2015 , ... From blood to food ... those cells from their surroundings for research, diagnostics, and cell therapy—also known as ... this, Ann Arbor-based startup Akadeum Life Sciences is developing a radically ...
(Date:10/8/2015)... Oct. 8, 2015   Intrexon Corporation (NYSE: ... announced the appointment of Joseph L. Vaillancourt ... Nir Nimrodi who continues in his role ... Intrexon,s endeavors to generate sustainable, biologically based solutions to ... where he held a variety of key roles including, ...
(Date:10/8/2015)...  ATCC, the premier global biological materials resource and ... by The Michael J. Fox Foundation for Parkinson,s Research ... and biotechnology organizations committed to speed a cure for ... , and more than 5 million worldwide, have ... , and more than 5 million worldwide, have ...
Breaking Biology Technology:
... processes with enterprise-centric Internet tools is hardly new, but one ... that reluctant business leaders need an education in Web 2.0. ... to a lack of information. Building on Internet expert Tim ... bloggers like Dion Hinchcliffe , Rod Boothby , ...
... pressure from expiring patents, generic drugs, and increasing ... pharmaceutical companies are increasingly turning to innovative biotechnology ... produce new business opportunities. , ,At a recent ... Device Association , pharmaceutical company representatives from ...
... Wis. - People usually enter contests to win prizes, ... no exception to the rule. About $450,000 in cash and ... years. , ,But the real prize in this statewide contest ... a splash. , ,Since its birth in 2004, the Governor's ...
Cached Biology Technology:
(Date:10/9/2015)... 09 2015 ... the "Samsung Galaxy S6 Fingerprint Sensor ... their offering. --> ) ... "Samsung Galaxy S6 Fingerprint Sensor - Reverse ... --> Research and Markets ( ...
(Date:10/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), ... today that it will report financial results for ... October 22, 2015, after the close of market. ... for analysts and investors at 2:00 p.m. PT ... forward-looking information. ). A ...
(Date:10/8/2015)... 8. Oktober 2015 Die Track ... Unternehmen des Bereiches Tracking, hat heute bekannt ... Gefängnisbehörde Virginias (Department of Corrections – DOC) ... für alle Strafen geliefert werden, die der ... Präsident für den Amerikanischen Kontinent der Track ...
Breaking Biology News(10 mins):
... by Stephen Dalton, professor and Georgia Research Alliance Eminent ... has been awarded $9.2 million as part of a ... General Medical Sciences, part of the National Institutes of ... biochemistry and molecular biology, will address the molecular underpinnings ...
... Models & Mechanisms ( DMM ) is the first ... model organisms to advance human health. Published by the ... biomedical research journal which officially launched its inaugural issue both ... DMM focuses on human disease and the research ...
... they have also calculated that the bite force of ... Carcharodon megalodon (also known as Big Tooth) ... the most formidable carnivore ever to have existed. ... Newcastle University, NSW Department of Primary Industries Fisheries (Australia) ...
Cached Biology News: